✦ LIBER ✦

Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer

✍ Scribed by Ben Tran; Scott Kopetz; Jeanne Tie; Peter Gibbs; Zhi-Qin Jiang; Christopher H. Lieu; Atin Agarwal; Dipen M. Maru; Oliver Sieber; Jayesh Desai

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 293 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26086

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Allelic loss of chromosome 17p, mutation

Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer

✍ Masahiro Watatani; Toshihiro Yoshida; Kosaku Kuroda; Shintaro Ieda; Masayuki Yas 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 575 KB

## BACKGROUND. Epidemiologic and genetic studies suggest that cancer of the right and left sides of the bowel arise through different mechanisms. To investigate the molecular mechanisms, allelic loss of chromosome 17p, p53 mutations, and microsatellite instability were analyzed in colorectal cance

The impact of new chemotherapeutic and h

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer

✍ Stephen K. Chia; Caroline H. Speers; Yulia D'yachkova; Anna Kang; Suzanne Malfai 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND. Over the past decade, a number of new therapeutic agents have become available in the treatment of metastatic breast cancer (MBC). This study characterized the use and assessed the impact on survival of population‐based access to new agents for the treatment of MBC. ##

A population-based study evaluating the

A population-based study evaluating the impact of sunitinib on overall survival in the treatment of patients with metastatic renal cell cancer

✍ Daniel Y. C. Heng; Kim N Chi; Nevin Murray; Tao Jin; Jorge A Garcia; Ronald M Bu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 1 views

## Abstract ## BACKGROUND: Sunitinib has replaced interferon (IFN) as a first‐line standard of care in the treatment of metastatic renal cell carcinoma (RCC). This study aimed to determine overall survival and to confirm effectiveness in a population that includes poor prognosis patients. ## METH